Subretinal fluid resolution in the fellow eye after unilateral aflibercept injection in bilateral neovascular age-related macular degeneration: Coincidence or systemic effect?

Arch Soc Esp Oftalmol (Engl Ed)May 25, 2026 (epub)

R Demirel, S Gültekin Irgat, H I Bike

✦ AI-curated · Sources linked

Case in brief

A 63-year-old woman with bilateral neovascular age-related macular degeneration (nAMD) developed new subretinal fluid (SRF) in her left eye, which had best-corrected visual acuity of 0.8, while receiving treat-and-extend aflibercept therapy in the right eye. To avoid injection-related risks in the better-seeing eye, clinicians treated only the right eye. Three weeks later, optical coherence tomography showed complete resolution of left-eye SRF. The fluid remained absent for 8 weeks before recurring.

What made this case unusual

SRF resolved in the untreated fellow eye after unilateral aflibercept injection, then recurred. The observation raises the possibility of a temporary systemic anti-VEGF effect on fellow-eye choroidal neovascularisation activity.

Diagnostic / clinical pearl

After unilateral anti-VEGF treatment, fellow-eye SRF may resolve temporarily; this single case cannot establish a systemic treatment effect or guide clinical practice.

Source

Published in Arch Soc Esp Oftalmol (Engl Ed). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.